These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30588010)

  • 1. Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells.
    Li X; Zhu G; Yao X; Wang N; Hu R; Kong Q; Zhou D; Long L; Cai J; Zhou W
    Onco Targets Ther; 2018; 11():8977-8985. PubMed ID: 30588010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celastrol inhibits mouse B16-F10 melanoma cell survival by regulating the PI3K/AKT/mTOR signaling pathway and repressing HIF-1α expression.
    Zhao P; He XB; Chen XY; Li ZL; Xing WJ; Liu W; Ren C; Han XD; Guo B
    Discov Oncol; 2024 May; 15(1):178. PubMed ID: 38771435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.
    Yang H; Chen D; Cui QC; Yuan X; Dou QP
    Cancer Res; 2006 May; 66(9):4758-65. PubMed ID: 16651429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells.
    Zhang T; Hamza A; Cao X; Wang B; Yu S; Zhan CG; Sun D
    Mol Cancer Ther; 2008 Jan; 7(1):162-70. PubMed ID: 18202019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.
    Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z
    Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells.
    Chen G; Zhang X; Zhao M; Wang Y; Cheng X; Wang D; Xu Y; Du Z; Yu X
    BMC Cancer; 2011 May; 11():170. PubMed ID: 21569548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations Y493G and K546D in human HSP90 disrupt binding of celastrol and reduce interaction with Cdc37.
    Peng B; Gu YJ; Wang Y; Cao FF; Zhang X; Zhang DH; Hou J
    FEBS Open Bio; 2016 Jul; 6(7):729-34. PubMed ID: 27398312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.
    Han X; Sun S; Zhao M; Cheng X; Chen G; Lin S; Guan Y; Yu X
    PLoS One; 2014; 9(11):e112470. PubMed ID: 25383959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celastrol: Molecular targets of Thunder God Vine.
    Salminen A; Lehtonen M; Paimela T; Kaarniranta K
    Biochem Biophys Res Commun; 2010 Apr; 394(3):439-42. PubMed ID: 20226165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study.
    Zhou YX; Huang YL
    Chin Med J (Engl); 2009 Jul; 122(14):1666-73. PubMed ID: 19719969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner.
    Lee JY; Lee BH; Kim ND; Lee JY
    J Ethnopharmacol; 2015 Aug; 172():254-60. PubMed ID: 26116162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer effect of celastrol on human triple negative breast cancer: possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways.
    Shrivastava S; Jeengar MK; Reddy VS; Reddy GB; Naidu VG
    Exp Mol Pathol; 2015 Jun; 98(3):313-27. PubMed ID: 25818165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα
    Zeng D; Zhang L; Luo Q
    Front Pharmacol; 2023; 14():1124240. PubMed ID: 36874033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celastrol inhibits colon cancer cell proliferation by downregulating miR-21 and PI3K/AKT/GSK-3β pathway.
    Ni H; Han Y; Jin X
    Int J Clin Exp Pathol; 2019; 12(3):808-816. PubMed ID: 31933888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer.
    Gao Y; Zhou S; Pang L; Yang J; Li HJ; Huo X; Qian SY
    Free Radic Res; 2019 Mar; 53(3):324-334. PubMed ID: 30773944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Anticancer Effect of Celastrol on Hepatocellular Carcinoma by Suppressing CXCR4-related Signal and Impeding Tumor Growth in Vivo.
    Kun-Ming C; Chih-Hsien C; Chen-Fang L; Ting-Jung W; Hong-Shiue C; Wei-Chen L
    Arch Med Res; 2020 May; 51(4):297-302. PubMed ID: 32169299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties.
    Jiang F; Wang HJ; Bao QC; Wang L; Jin YH; Zhang Q; Jiang D; You QD; Xu XL
    Bioorg Med Chem; 2016 Nov; 24(21):5431-5439. PubMed ID: 27647369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer.
    Kannaiyan R; Shanmugam MK; Sethi G
    Cancer Lett; 2011 Apr; 303(1):9-20. PubMed ID: 21168266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway.
    Zhu Y; Liu X; Zhao P; Zhao H; Gao W; Wang L
    Front Pharmacol; 2020; 11():25. PubMed ID: 32116702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells.
    Liu X; Zhao P; Wang X; Wang L; Zhu Y; Song Y; Gao W
    J Exp Clin Cancer Res; 2019 May; 38(1):184. PubMed ID: 31053160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.